Somatic mutations identification of FGFR3 among HCC egyptian patients using NGS [electronic resource]
Language: English Summary language: Arabic Description: 103 - 111 pUniform titles:- Egyptian journal of genetics and cytology, 2022. v. 51 (2)
Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
![]() |
Main | ART EJGC V51 No2 2 (Browse shelf(Opens below)) | Available |
Browsing Main shelves Close shelf browser (Hides shelf browser)
Includes bibliographic reference
Hepatocellular carcinoma (HCC) is the most prominent liver cancer, accounting for 85% of primary liver malig-nancies.
It is a very aggressive tumor, hav-ing a terrible prognosis and poor survival rate (Mir et al., 2021). HCC is ranked the sixth most common type of cancer and the third leading cause of cancer-related mortali-ties worldwide (Singh et al., 2020).
HCC incidences arise in complica-tions associated with chronic liver disease like cirrhosis, endemic hepatitis B virus (HBV)/hepatitis C virus (HCV) infections, nonalcoholic fatty liver disease, and alcohol-related liver disease (Torre et al., 2015).
Keywords: Hepatocellular carcinoma, Next generation sequencing, fibroblast growth factor receptor 3.
Summary in Arabic
There are no comments on this title.